Literature DB >> 5312203

Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia.

K A Western, D R Perera, M G Schultz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312203     DOI: 10.7326/0003-4819-73-5-695

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  27 in total

1.  In vitro inhibition of platelet function and coagulation by pentamidine isethionate.

Authors:  S J Kempin; C W Jackson; C C Edwards
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

2.  Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host.

Authors:  F W Ryning; J Mills
Journal:  West J Med       Date:  1979-01

Review 3.  Pentamidine. A risk-benefit analysis.

Authors:  B Wispelwey; R Pearson
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome.

Authors:  M W Lambertus; A R Murthy; P Nagami; M B Goetz
Journal:  West J Med       Date:  1988-11

5.  Use and safety of antimicrobial agents during pregnancy.

Authors:  A W Chow; P J Jewesson
Journal:  West J Med       Date:  1987-06

6.  Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness.

Authors:  U Bronner; L L Gustafsson; F Doua; O Ericsson; T Miézan; M Rais; L Rombo
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

7.  Infection in immunodepressed patients. The approach to diagnosis and treatment.

Authors:  E H Nauta; R van Furth
Journal:  Infection       Date:  1975       Impact factor: 3.553

8.  Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.

Authors:  R T Dorr; J R Powell; M Heick; D W Barry
Journal:  Postgrad Med J       Date:  1981-02       Impact factor: 2.401

Review 9.  Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia.

Authors:  K L Goa; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

10.  Acute, rapidly progressive renal failure with simultaneous use of amphotericin B and pentamidine.

Authors:  D Antoniskis; R A Larsen
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.